Burleson & Company, LLC Haleon PLC Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Haleon PLC stock. As of the latest transaction made, Burleson & Company, LLC holds 458 shares of HLN stock, worth $4,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
458
Previous 458
-0.0%
Holding current value
$4,905
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HLN
# of Institutions
624Shares Held
422MCall Options Held
165KPut Options Held
26.7K-
Dodge & Cox San Francisco, CA180MShares$1.93 Billion0.94% of portfolio
-
Clearbridge Investments, LLC New York, NY41.8MShares$447 Million0.29% of portfolio
-
Harding Loevner LP Bridgewater, NJ25.6MShares$274 Million1.2% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14MShares$150 Million0.05% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA9.05MShares$96.9 Million0.15% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $49.5B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...